Patent ID: 11931333
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 16:
17. A method of treating a herpes infection comprising applying a topical component of a two-component composition to a treatment site of a person in need thereof and orally administering an oral dosage form of the two-component composition to person,
the topical component comprising:
a liquid carrier comprising dimethyl sulfoxide DMSO and an aqueous diluent; and
an anti-viral component that is water soluble and comprises one or more of a quaternary ammonium compound, acyclovir, valacyclovir, famciclovir, or penciclovir in a concentration so that, when applied to the treatment site together with the DMSO, treats the herpes infection by providing anti-viral activity at the treatment site,
wherein the liquid carrier comprises 50-70% DMSO and 50-30% diluent and the at least one water soluble quaternary ammonium compound comprises benzalkonium chloride; and

the oral dosage form comprising lysine.